| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mario F Wulliman. Basal ganglia: insights into origins from lamprey brains. Current biology : CB. vol 21. issue 13. 2011-12-20. PMID:21741583. |
the lamprey brain has now been shown to have basal ganglia circuitry, with an output that acts tonically on midbrain and brainstem motor centers and is modulated by ascending dopaminergic input. |
2011-12-20 |
2023-08-12 |
Not clear |
| Timothy J Vickery, Marvin M Chun, Daeyeol Le. Ubiquity and specificity of reinforcement signals throughout the human brain. Neuron. vol 72. issue 1. 2011-12-07. PMID:21982377. |
a conventional approach to understanding the corresponding neural substrates focuses on the basal ganglia and its dopaminergic projections. |
2011-12-07 |
2023-08-12 |
human |
| Christos Krogias, Kija Hoffmann, Jens Eyding, Dirk Scheele, Christine Norra, Ralf Gold, Georg Juckel, Hans-Jörg Assio. Evaluation of basal ganglia, brainstem raphe and ventricles in bipolar disorder by transcranial sonography. Psychiatry research. vol 194. issue 2. 2011-12-06. PMID:21958513. |
echogenicities of dopaminergic basal ganglia structures were assessed for the first time in bipolar disorder. |
2011-12-06 |
2023-08-12 |
Not clear |
| Eun-Yee Jung, Insop Shi. Differential DAergic Control of D1 and D2 Receptor Agonist Over Locomotor Activity and GABA Level in the Striatum. Experimental neurobiology. vol 20. issue 3. 2011-11-23. PMID:22110374. |
the striatum, which is the major input station of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. |
2011-11-23 |
2023-08-12 |
mouse |
| Andreas Wree, Eilhard Mix, Alexander Hawlitschka, Veronica Antipova, Martin Witt, Oliver Schmitt, Reiner Beneck. Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease. Neurobiology of disease. vol 41. issue 2. 2011-11-22. PMID:20955797. |
central pathophysiological pathways of basal ganglia dysfunction imply a disturbed interaction of dopaminergic and cholinergic circuits. |
2011-11-22 |
2023-08-12 |
rat |
| Jeylan S Buyukdura, Shawn M McClintock, Paul E Croarki. Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 2. 2011-11-22. PMID:21044654. |
biological correlates may include abnormalities in the basal ganglia and dopaminergic pathways. |
2011-11-22 |
2023-08-12 |
Not clear |
| F L'Episcopo, C Tirolo, N Testa, S Caniglia, M C Morale, C Cossetti, P D'Adamo, E Zardini, L Andreoni, A E C Ihekwaba, P A Serra, D Franciotta, G Martino, S Pluchino, B Marchett. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Neurobiology of disease. vol 41. issue 2. 2011-11-22. PMID:21056667. |
emerging evidence points to reactive glia as a pivotal factor in parkinson's disease (pd) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp)-lesioned mouse model of basal ganglia injury, but whether astrocytes and microglia activation may exacerbate dopaminergic (daergic) neuron demise and/or contribute to daergic repair is presently the subject of much debate. |
2011-11-22 |
2023-08-12 |
mouse |
| Dimitra Giannakopoulou, Ioanna Armata, Ada Mitsacos, Pullani Shashidharan, Panagiotis Giompre. Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features. Journal of neural transmission (Vienna, Austria : 1996). vol 117. issue 12. 2011-11-14. PMID:21136125. |
modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features. |
2011-11-14 |
2023-08-12 |
mouse |
| Dimitra Giannakopoulou, Ioanna Armata, Ada Mitsacos, Pullani Shashidharan, Panagiotis Giompre. Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features. Journal of neural transmission (Vienna, Austria : 1996). vol 117. issue 12. 2011-11-14. PMID:21136125. |
there are data supporting the hypothesis that basal ganglia dysfunction, and specifically dopaminergic system dysfunction, plays a role in dystonia. |
2011-11-14 |
2023-08-12 |
mouse |
| Dimitra Giannakopoulou, Ioanna Armata, Ada Mitsacos, Pullani Shashidharan, Panagiotis Giompre. Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features. Journal of neural transmission (Vienna, Austria : 1996). vol 117. issue 12. 2011-11-14. PMID:21136125. |
in the present study, we used hyperkinetic transgenic mice generated as a model of dyt1 dystonia and compared the basal ganglia dopaminergic system between transgenic mice exhibiting hyperkinesia (affected), transgenic mice not showing movement abnormalities (unaffected), and non-transgenic littermates. |
2011-11-14 |
2023-08-12 |
mouse |
| Dimitra Giannakopoulou, Ioanna Armata, Ada Mitsacos, Pullani Shashidharan, Panagiotis Giompre. Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features. Journal of neural transmission (Vienna, Austria : 1996). vol 117. issue 12. 2011-11-14. PMID:21136125. |
our results show selective neurochemical changes in the basal ganglia dopaminergic system, suggesting a possible involvement in the pathophysiology of dystonia-like motor hyperactivity. |
2011-11-14 |
2023-08-12 |
mouse |
| Amparo Novejarque, Nicolás Gutiérrez-Castellanos, Enrique Lanuza, Fernando Martínez-Garcí. Amygdaloid projections to the ventral striatum in mice: direct and indirect chemosensory inputs to the brain reward system. Frontiers in neuroanatomy. vol 5. 2011-11-10. PMID:22007159. |
since previous work indicates that the dopaminergic tegmento-striatal pathway is not involved in pheromone reward, the present report explores alternative pathways linking the vomeronasal system with the tegmento-striatal system (the limbic basal ganglia) by means of tract-tracing experiments studying direct and indirect projections from the chemosensory amygdala to the ventral striato-pallidum. |
2011-11-10 |
2023-08-12 |
mouse |
| Jos J Adam, Hanna van Houdt, Bart Scholtissen, Veerle Visser-Vandewalle, Ania Winogrodzka, Annelien Duit. Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance. Neuroscience letters. vol 500. issue 2. 2011-11-07. PMID:21704125. |
in pd this mechanism is severely compromised but it can be remediated by dopaminergic medication and dbs, suggesting an essential role of the basal ganglia in the selection and suppression of competing responses. |
2011-11-07 |
2023-08-12 |
Not clear |
| M S Nandhu, Jes Paul, Korah P Kuruvila, Pretty M Abraham, Sherin Antony, C S Paulos. Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: functional recovery with bone marrow cells, serotonin and GABA. Molecular and cellular biochemistry. vol 353. issue 1-2. 2011-10-18. PMID:21384157. |
in parkinson's disease, degeneration of dopaminergic neurons involves motor structures including basal ganglia and cerebellum. |
2011-10-18 |
2023-08-12 |
rat |
| Soon Won Choi, Sigrid Eckardt, Ruhel Ahmad, Wanja Wolber, K John McLaughlin, Anna-Leena Sirén, Albrecht M Mülle. Two paternal genomes are compatible with dopaminergic in vitro and in vivo differentiation. The International journal of developmental biology. vol 54. issue 11-12. 2011-09-26. PMID:21404193. |
patient derived stem cell-based therapies are considered a future treatment option for parkinson´s disease, a chronic and progressive brain neurodegenerative disorder characterized by depletion of dopaminergic neurons in the basal ganglia. |
2011-09-26 |
2023-08-12 |
Not clear |
| Elaine Del-Bel, Fernando Eduardo Padovan-Neto, Rita Raisman-Vozari, Marcio Lazzarin. Role of nitric oxide in motor control: implications for Parkinson's disease pathophysiology and treatment. Current pharmaceutical design. vol 17. issue 5. 2011-08-09. PMID:21375483. |
according to classical thinking about parkinson's disease, loss of dopaminergic input from the substantia nigra pars compacta leads to overactivity and underactivity of the indirect and direct output pathways, respectively, in the basal ganglia. |
2011-08-09 |
2023-08-12 |
mouse |
| Thomas F Münte, Marcus Heldmann, Hermann Hinrichs, Josep Marco-Pallares, Ulrike M Krämer, Volker Sturm, Hans-Jochen Heinz. Nucleus Accumbens is Involved in Human Action Monitoring: Evidence from Invasive Electrophysiological Recordings. Frontiers in human neuroscience. vol 1. 2011-07-14. PMID:18958225. |
action monitoring, that is, error detection and correction, is thought to be supported by a system involving the dopaminergic midbrain, the basal ganglia, and the medial prefrontal cortex. |
2011-07-14 |
2023-08-12 |
human |
| Peter Redgrave, Veronique Coizet, Eliane Comoli, John G McHaffie, Mariana Leriche, Nicolas Vautrelle, Lauren M Hayes, Paul Overto. Interactions between the Midbrain Superior Colliculus and the Basal Ganglia. Frontiers in neuroanatomy. vol 4. 2011-07-14. PMID:20941324. |
the sc also provides afferent signals to the other principal input nuclei of the basal ganglia, the dopaminergic neurones in substantia nigra and to the subthalamic nucleus. |
2011-07-14 |
2023-08-12 |
Not clear |
| Karen S Rommelfanger, Thomas Wichman. Extrastriatal dopaminergic circuits of the Basal Ganglia. Frontiers in neuroanatomy. vol 4. 2011-07-14. PMID:21103009. |
extrastriatal dopaminergic circuits of the basal ganglia. |
2011-07-14 |
2023-08-12 |
Not clear |
| Karen S Rommelfanger, Thomas Wichman. Extrastriatal dopaminergic circuits of the Basal Ganglia. Frontiers in neuroanatomy. vol 4. 2011-07-14. PMID:21103009. |
dopamine has long been identified as an important modulator of basal ganglia function in the striatum, and disturbances of striatal dopaminergic transmission have been implicated in diseases such as parkinson's disease (pd), addiction and attention deficit hyperactivity disorder. |
2011-07-14 |
2023-08-12 |
Not clear |